RxDoctor Payments Data

Juliette Gittinger, DO

Family Medicine · Tarpon Springs, FLNPI 1144201245

Payments from drug & device makers

$1,948in general payments, 2019–2025

Across 117 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$850
  • Novo Nordisk$364
  • Lilly USA, LLC$145
  • Boehringer Ingelheim$112
  • Amgen$76
  • Pfizer$69
  • plus $331 from 12 others

What the payments were for

  • Food & beverage$1,942100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,948 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$56,334
Medicare patients
252
Services billed
635

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban41$36,510
MounjaroTirzepatide26$31,211
OzempicSemaglutide19$27,968
FarxigaDapagliflozin Propanediol23$22,394
Repatha SureclickEvolocumab15$16,886
MupirocinMupirocin Calcium11$14,623
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$4,493
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$2,519
SynthroidLevothyroxine Sodium44$2,009
Levothyroxine Sodium257$1,930
Ezetimibe34$1,595
CreonLipase/Protease/Amylase11$1,514
Amlodipine Besylate206$1,154
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide39$1,146
Rosuvastatin Calcium106$1,127

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$69$36,51041 claims
Lilly USA, LLCMounjaro$145$31,21126 claims
Novo NordiskOzempic$364$27,96819 claims
AstraZenecaFarxiga$850$22,39423 claims
AbbVieSynthroid, Creon$24$3,52355 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Tarpon Springs

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →